Current food systems are unable to meet the needs of millions of people who suffer from hunger, micronutrient deficiencies or diet-related chronic diseases and are highly vulnerable to environmental stressors.
The newly released annual report on the Global Partnership for Education (GPE) Knowledge and Innovation Exchange (KIX) shows that the initiative — the largest education fund of its kind — is closing the gap between research innovation and policy impact.
IDRC, the Israel Science Foundation, the Azrieli Foundation and the Canadian Institutes of Health Research (CIHR) are pleased to announce the second research competition under Phase II of the Joint Canada-Israel Health Research Program.
The Canadian Institutes of Health Research (CIHR) and IDRC, on behalf of the Government of Canada, are supporting a rapid research response to outbreaks of Monkeypox in Canada and Africa. The Monkeypox Rapid Research Response competition will launch the week of August 1, 2022.
An IDRC-supported special issue on gender-lens investing was recently published in the Journal of Sustainable Finance and Investment. Gender-lens investing is a growing arm of sustainable finance that considers and measures contributions to gender equality and financial returns.
IDRC and the Minister of International Development, the Honourable Harjit Sajjan, are pleased to announce that Dr. Dorothy Nyambi has been appointed as Chairperson of IDRC’s Board of Governors, Nurjehan Mawani has been appointed as governor and Gilles Rivard, Purnima Mane and Akwasi Aidoo have been reappointed as governors.
Zulfiqar A. Bhutta, a long-time IDRC grantee, has been awarded the John Dirks Canada Gairdner 2022 Global Health Award “for the development and evaluation of evidence-based interventions in child and maternal health for marginalized populations, focusing on outcomes for the ‘first thousand days’ of life.”
For many people, the raison d’être of global health is the achievement of health equity for all people worldwide. Reaffirming this view is the United Nations’ Sustainable Development Goal 3, which seeks to “ensure healthy lives and promote well-being for all at all ages.” Yet, after decades of programming and billions of dollars invested in global health, alarming health inequities persist across and within countries. The current COVID-19 pandemic has further exacerbated these health inequities, underscoring the need for the field of global health to do more and to do better.
This project enables increased participation of Latin American research institutions, in collaboration with their national science granting councils, in the Trans-Atlantic Platform (T-AP) call for proposals on Recovery, Renewal and Resilience (RRR) in a Post-Pandemic World.
Colistin is considered a last-resort antimicrobial for treatment of infections with multidrug-resistant bacteria, classified by the World Health Organization (WHO) as ‘highest prioritized, critically important for human medicine’.